Market Overview:
The global optical preclinical imaging devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for early and accurate diagnosis of diseases, rising prevalence of chronic diseases, and technological advancements in optical preclinical imaging devices. Based on type, the global optical preclinical imaging devices market is segmented into fluorescence and bioluminescence. The fluorescence segment is expected to account for a larger share of the global market than the bioluminescence segment during the forecast period. This can be attributed to factors such as growing use of fluorescent dyes in research applications and increasing demand for early diagnosis of diseases. Based on application, the global optical preclinical imaging devices market is divided into pharma and biotech companies, research institutes, hospitals, and others (including contract research organizations [CROs] and medical device manufacturers). The pharma and biotech companies segment is expected to account for a larger share of the global market than other segments during the forecast period. This can be attributed to rising investments by pharmaceutical companies in R&D activities aimed at developing new drugs/therapies.
Product Definition:
Optical preclinical imaging devices are used to image tissues and organs in the body. This can be used for medical diagnosis and research purposes.
Fluorescence:
Fluorescence is the transition of an unstable intermediate to a longer-lived one through a chemical reaction. The most common example of fluorescence is the use of it in microscopy where it is used to visualize cellular components by labeling them with fluorescent dyes. It can also be used for other applications such as detection and identification of pathogens or chemicals, which are difficult to identify using other methods such as absorbance or scattering.
Bioluminescence:
Bioluminescence is the light produced by living organisms. It plays a major role in various biological processes such as vision, chemical signaling, and cellular communication. Bioluminescence imaging uses bioluminescent signals to visualize internal body structures and study disease-related changes at subcellular levels. Optical Preclinical Imaging (OPI) devices are used for preclinical research purposes to study the effect of new drug treatments on living subjects without harming them.
Application Insights:
The others application segment includes government and public health, non-profit organizations, and hospitals. The usage of these devices in the aforementioned applications is relatively low as compared to their usage in other applications such as research institutes and pharmaceutical companies. However, the demand for optical imaging devices is expected to grow over the forecast period owing to increasing adoption of these devices by researchers at various research institutes across the globe. Optical imaging has proven beneficial in various studies such as drug discovery & development; toxicology; disease diagnosis; preclinical efficacy testing; biomarker profiling & validation for cancer diagnostics & treatment planning etc.
The growing use of bioluminescence technology for studying cellular processes including cell proliferation, apoptosis, migration/invasion etc., makes it a preferred tool among several researchers across all major academic institutions worldwide due to its high specificity and efficiency coupled with ease of use.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as local presence of major players, high disposable income, and increasing investment by companies for R&D in this region. Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing number of research institutes and rising healthcare expenditure by countries such as China & India. Moreover, growing awareness about advanced technologies for disease diagnosis will drive regional growth during the forecast period.
Infectious Diseases was one of the largest revenue-generating segment in 2017 due to presence of developed economies with well-established healthcare infrastructure coupled with favorable government initiatives pertaining preclinical optical imaging devices market development programmes across these regions which would ultimately drive growth over next eight years from 2018 till 2030 time frame.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.8% from 2016 to 2021. This is primarily due to the advantages offered by these surgeries over traditional open surgery procedures, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. Optical preclinical imaging devices are ideally suited for use in minimally invasive surgeries as they offer high-resolution images with minimal tissue damage.
- Growing demand for personalized medicine: The global market for personalized medicine is expected to grow at a CAGR of 16% from 2016 to 2021. This growth can be attributed to the increasing prevalence of chronic diseases, rising healthcare costs, and the growing trend of using biomarkers for disease diagnosis and treatment planning. Optical preclinical imaging devices can help in the development of personalized medicines by providing high-resolution images of diseased tissues with great accuracy.
Scope Of The Report
Report Attributes
Report Details
Report Title
Optical Preclinical Imaging Devices Market Research Report
By Type
Fluorescence, Bioluminescence
By Application
Pharma and Biotech Companies, Research Institutes, Hospital, Others
By Companies
ThermoFisher, Bruker Corporation, Perkin Elmer, MR Solutions, BioTek Instruments, Milabs, Fujifilm Holdings Corporation, Magnetic Insight, MBF Bioscience, Mediso, LI-COR Biosciences, Aspect Imaging, TriFoil Imaging, Miltenyi Biotech GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Optical Preclinical Imaging Devices Market Report Segments:
The global Optical Preclinical Imaging Devices market is segmented on the basis of:
Types
Fluorescence, Bioluminescence
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharma and Biotech Companies, Research Institutes, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ThermoFisher
- Bruker Corporation
- Perkin Elmer
- MR Solutions
- BioTek Instruments
- Milabs
- Fujifilm Holdings Corporation
- Magnetic Insight
- MBF Bioscience
- Mediso
- LI-COR Biosciences
- Aspect Imaging
- TriFoil Imaging
- Miltenyi Biotech GmbH
Highlights of The Optical Preclinical Imaging Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fluorescence
- Bioluminescence
- By Application:
- Pharma and Biotech Companies
- Research Institutes
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Optical Preclinical Imaging Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Optical preclinical imaging devices are medical devices that use light to image the body. They can be used to diagnose and treat diseases, as well as help researchers study the body.
Some of the key players operating in the optical preclinical imaging devices market are ThermoFisher, Bruker Corporation, Perkin Elmer, MR Solutions, BioTek Instruments, Milabs, Fujifilm Holdings Corporation, Magnetic Insight, MBF Bioscience, Mediso, LI-COR Biosciences, Aspect Imaging, TriFoil Imaging, Miltenyi Biotech GmbH.
The optical preclinical imaging devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Optical Preclinical Imaging Devices Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Optical Preclinical Imaging Devices Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Optical Preclinical Imaging Devices Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Optical Preclinical Imaging Devices Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Optical Preclinical Imaging Devices Market Size & Forecast, 2018-2028 4.5.1 Optical Preclinical Imaging Devices Market Size and Y-o-Y Growth 4.5.2 Optical Preclinical Imaging Devices Market Absolute $ Opportunity
Chapter 5 Global Optical Preclinical Imaging Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Optical Preclinical Imaging Devices Market Size Forecast by Type
5.2.1 Fluorescence
5.2.2 Bioluminescence
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Optical Preclinical Imaging Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Optical Preclinical Imaging Devices Market Size Forecast by Applications
6.2.1 Pharma and Biotech Companies
6.2.2 Research Institutes
6.2.3 Hospital
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Optical Preclinical Imaging Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Optical Preclinical Imaging Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Optical Preclinical Imaging Devices Analysis and Forecast
9.1 Introduction
9.2 North America Optical Preclinical Imaging Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Optical Preclinical Imaging Devices Market Size Forecast by Type
9.6.1 Fluorescence
9.6.2 Bioluminescence
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Optical Preclinical Imaging Devices Market Size Forecast by Applications
9.10.1 Pharma and Biotech Companies
9.10.2 Research Institutes
9.10.3 Hospital
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Optical Preclinical Imaging Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Optical Preclinical Imaging Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Optical Preclinical Imaging Devices Market Size Forecast by Type
10.6.1 Fluorescence
10.6.2 Bioluminescence
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Optical Preclinical Imaging Devices Market Size Forecast by Applications
10.10.1 Pharma and Biotech Companies
10.10.2 Research Institutes
10.10.3 Hospital
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Optical Preclinical Imaging Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Optical Preclinical Imaging Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Optical Preclinical Imaging Devices Market Size Forecast by Type
11.6.1 Fluorescence
11.6.2 Bioluminescence
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Optical Preclinical Imaging Devices Market Size Forecast by Applications
11.10.1 Pharma and Biotech Companies
11.10.2 Research Institutes
11.10.3 Hospital
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Optical Preclinical Imaging Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Optical Preclinical Imaging Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Optical Preclinical Imaging Devices Market Size Forecast by Type
12.6.1 Fluorescence
12.6.2 Bioluminescence
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Optical Preclinical Imaging Devices Market Size Forecast by Applications
12.10.1 Pharma and Biotech Companies
12.10.2 Research Institutes
12.10.3 Hospital
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Optical Preclinical Imaging Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Optical Preclinical Imaging Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Optical Preclinical Imaging Devices Market Size Forecast by Type
13.6.1 Fluorescence
13.6.2 Bioluminescence
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Optical Preclinical Imaging Devices Market Size Forecast by Applications
13.10.1 Pharma and Biotech Companies
13.10.2 Research Institutes
13.10.3 Hospital
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Optical Preclinical Imaging Devices Market: Competitive Dashboard
14.2 Global Optical Preclinical Imaging Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ThermoFisher
14.3.2 Bruker Corporation
14.3.3 Perkin Elmer
14.3.4 MR Solutions
14.3.5 BioTek Instruments
14.3.6 Milabs
14.3.7 Fujifilm Holdings Corporation
14.3.8 Magnetic Insight
14.3.9 MBF Bioscience
14.3.10 Mediso
14.3.11 LI-COR Biosciences
14.3.12 Aspect Imaging
14.3.13 TriFoil Imaging
14.3.14 Miltenyi Biotech GmbH